Skip to main content
Major Depressive Disorder
resource center
Menu
Menu
Main navigation
Home
Featured Diseases & Conditions
COVID-19
Depression Care 360
HIV Management
HIV Prevention
Pediatric Influenza
Psoriatic Arthritis
Resources
Commentary
Disease State Directory
FDA Alerts
Pearls
Podcasts
Polls
Q&As
Quizzes
Research Summaries
Slideshows
Videos
Events & Education
Consultant360's Practical Updates in Primary Care
CME
Publication
About Consultant
Consultant Current Issue
Consultant Early View
Consultant Archive
Author Guidelines
Case Report Templates
FAQ
Advertising With Consultant360
Search
Login
Menu
Menu
Main navigation
Home
Featured Diseases & Conditions
COVID-19
Depression Care 360
HIV Management
HIV Prevention
Pediatric Influenza
Psoriatic Arthritis
Resources
Commentary
Disease State Directory
FDA Alerts
Pearls
Podcasts
Polls
Q&As
Quizzes
Research Summaries
Slideshows
Videos
Events & Education
Consultant360's Practical Updates in Primary Care
CME
Publication
About Consultant
Consultant Current Issue
Consultant Early View
Consultant Archive
Author Guidelines
Case Report Templates
FAQ
Advertising With Consultant360
Major Depressive Disorder
Resource Center
Resources
Depression Care360
Clinical Update
Research Summaries
Interactive
Polls
Quizzes
FDA Alerts
major depression
major depression
FDA Approves 3-Minute, Noninvasive Treatment for Depression
08/23/2018
The US Food and Drug Administration has approved a shortened version of existing brain stimulation protocol for treatment-resistant major depressive disorder.
08/23/2018